International Psoriasis Council

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

IPC Europe Virtual Masterclass​

Course Overview

The IPC Virtual Psoriasis Masterclass is designed for dermatologists who are making treatment decisions and managing patients with psoriasis and are interested in specializing in psoriasis.

Over the five days of the course, IPC’s world-renowned experts will cover a variety of topics including the pathogenesis of psoriasis, new and emerging therapies and how to be an advocate for your patient.

The Masterclass agenda has been carefully developed to provide knowledge for daily use to the practicing dermatologist in an intimate environment designed to maximize faculty/participant interactions. Through lectures, panels, case-based discussions and question-answer sessions, attendees will obtain practical and important information for their clinical practice.

The IPC Masterclass is open to dermatologists who meet the following criteria:

  • A diploma, 1st part MSc or higher degree in internal medicine or dermatology
  • Practicing internal medicine or dermatology within a governmental establishment i.e. university hospital, public hospitals, rural hospitals, etc.
  • At least 3 years of dermatology practice
  • General practitioners or dermatologists interested in psoriasis and who see at least two case of psoriasis per week

The IPC Virtual Psoriasis Masterclass, Sessions 1-5, Virtual, Romania, have been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 10 European CME credits (ECMEC®s)*. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. For full details, please see the EACCME Accreditation Statements.
*Each of five sessions is accredited with 2 ECMEC®s.

There is no cost to attend the program, but space is limited. The application deadline is September 22, 2022.

Timezones:
Hungary/Poland/Serbia Time: 2:00-4:00 pm
Bulgaria/Greece/Romania Time: 3:00-5:00 pm

Agendas 

WELCOME + INTRODUCTION
George Sorin Tiplica

Psoriasis: From Pathophysiology to Targeted Therapy
Wolf Henning Boehncke

Phenotypes of Psoriasis
Peter van de Kerkhof


Comorbidities of Psoriasis
Luigi Naldi

Psoriasis: Treat to Target
Ulrich Mrowietz

CLOSING COMMENTS
Lluís Puig

WELCOME + INTRODUCTION
Lluís Puig

Psoriasis: Assessment of Disease Severity in Clinical Practice
Marcus Schmitt-Egenolf

Optimizing Use of Topical Therapy and Conventional Systemic Agents in Psoriasis
Peter van de Kerkhof

Psoriatic Arthritis: Early Diagnosis and Management
Alice Gottlieb

Management of Pustular Psoriasis
Hervé Bachelez

Global Psoriasis Atlas
Darren Ashcroft

CLOSING COMMENTS
George Sorin Tiplica

WELCOME + INTRODUCTION
George-Sorin Tiplica

Psoriasis in Special Areas (Palms and Soles, Nails, Scalp, Genital Areas)
George-Sorin Tiplica

Management of Erythrodermic Psoriasis
Deepak Balak

Role of Phototherapy in the Management of Psoriasis
Mohamed El-Komy

Lifestyle & Psoriasis
Jörg Prinz


Optimizing the Use of Biologics and Biosimilars in Psoriasis
Arnon Cohen

CLOSING COMMENTS
Lluís Puig

WELCOME + INTRODUCTION
George-Sorin Tiplica

Management of Psoriasis in Children
Carmen Salavastru

Management of Psoriasis in Pregnant and Breastfeeding Women
Mahira Hamdy El Sayed

CHALLENGING PSORIASIS CASE WORKSHOP – FACULTY
Case 1: Recalcitrant Psoriasis in Obesity
Adelina Sendrea

Case 2: Psoriasis with Hep B
TBD

Case 3: Patients with Strong FH of Malignancy, Personal History of Lymphoma or Breast Cancers
Marijana Vičić

Case 4: Patient with Tuberculosis and Psoriasis
Filip Rob

CLOSING COMMENTS
Lluís Puig

WELCOME + INTRODUCTION
Lluís Puig

Impact of the COVID-19 Pandemic on Management of Psoriasis; Role of Teledermatology
Alba Català

New and Emerging Therapy for Psoriasis
Lluís Puig

Role of Patient Support Groups in Psoriasis
Josef de Guzman

CHALLENGING PSORIASIS CASE WORKSHOP – PRESENTED BY DELEGATES

CLOSING COMMENTS
George-Sorin Tiplica and Lluís Puig

Program Co-Chairs 

Lluís Puig, MD, PhD

Hospital de la Santa Creu i Sant Pau

Barcelona, Spain

IPC Board Member

Bio

George-Sorin Tiplica, MD, PhD

Carol Davila University of Medicine and Pharmacy

Bucharest, Romania

Bio
Faculty 

Darren Ashcroft, BPharm, MSc, PhD, MRPharmS

University of Manchester

Manchester, United Kingdom

Bio

Hervé Bachelez, MD, PhD

Hôpital Saint-Louis, Imagine Institute for Human Genetic Diseases, University of Paris

Paris, France

IPC Vice President/President Elect

Bio

Deepak Balak, MD, PhD, MSc

LangeLand Hospital and Ghent University Hospital

Zoetermeer, Netherlands

Bio

Wolf-Henning Boehncke, MD, MA

Geneva University Hospital

Geneve, Switzerland

Bio

Alba Català Gonzalo, MD

Hospital Clínic de Barcelona

Barcelona, Spain

Bio

Arnon Cohen, MD, MPH, PhD

Clalit Health Services, Department of Quality Measures and Research

Tel Aviv, Israel

Bio

Josef de Guzman

PsorPhil

Manila, Philippines

Bio

Mohamed El-Komy, MD

Cairo University

Cairo, Egypt

Bio

Mahira El Sayed, MSc, MD

Ain Shams University

Cairo, Egypt

IPC Board Member

Bio

Alice Gottlieb, MD, PhD

Icahn School of Medicine at Mount Sinai

New York, New York, United States

Bio

Ulrich Mrowietz, MD

University Medical Center Schleswig-Holstein

Kiel, Germany

Bio

Luigi Naldi, MD

AULSS 8, Ospedale San Bortolo, Vicenza, Centro Studi GISED, Bergamo

Vicenza and Bergamo, Italy

Bio

Jörg Prinz, MD

Ludwig Maximilians University Munchen

Munich, Germany

Bio

Filip Rob, MD, PhD

Charles University

Prague, Czech Republic

Bio

Adelina-Maria Sendrea, MD

Colentina Clinical Hospital in Bucharest

Bucharest, Romania

Bio

Marcus Schmitt-Egenolf, MD, PhD

Umeå University

Umea, Sweden

Bio

Peter van de Kerkhof, MD, PhD

International Psoriasis Council

Amsterdam, Netherlands

Bio

Marijana Vičić, MD, PhD

University of Rijeka School of Medicine and
Clinical Hospital Centre of Rijeka

Rijeka, Croatia

Bio